tradingkey.logo

Cigna Group

CI

316.000USD

-0.830-0.26%
終値 06/25, 16:00ET15分遅れの株価
85.29B時価総額
24.84直近12ヶ月PER

Cigna Group

316.000

-0.830-0.26%
詳細情報 Cigna Group 企業名
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
企業情報
企業コードCI
会社名Cigna Group
上場日Apr 01, 1982
設立日2018
最高経営責任者「CEO」Mr. David M. Cordani, CPA
従業員数73500
証券種類Ordinary Share
決算期末Apr 01
本社所在地- -
都市- -
証券取引所NYSE Consolidated
- -
郵便番号- -
電話番号- -
ウェブサイト- -
企業コードCI
上場日Apr 01, 1982
設立日2018
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-3.82%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
64.33K
+18.95%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.73K
+2.44%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+2.83%
Dr. David J. Brailer, M.D., Ph.D.
Dr. David J. Brailer, M.D., Ph.D.
Executive Vice President, Chief Health Officer and Chief Transformation Officer
Executive Vice President, Chief Health Officer and Chief Transformation Officer
17.82K
+97.02%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
6.11K
+11.66%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+11.66%
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
6.11K
+11.66%
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
4.51K
+16.47%
Mr. George Kurian
Mr. George Kurian
Independent Director
Independent Director
3.78K
+20.32%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-3.82%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
64.33K
+18.95%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.73K
+2.44%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+2.83%
Dr. David J. Brailer, M.D., Ph.D.
Dr. David J. Brailer, M.D., Ph.D.
Executive Vice President, Chief Health Officer and Chief Transformation Officer
Executive Vice President, Chief Health Officer and Chief Transformation Officer
17.82K
+97.02%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
6.11K
+11.66%
収益内訳
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2018
事業別USD
会社名
収益
比率
Pharmacy revenues
185.36B
0.00%
Network revenues
105.34B
0.00%
Home delivery and specialty revenues
72.48B
0.00%
Fees and other revenues
14.79B
0.00%
Other revenues
11.54B
0.00%
Intercompany eliminations
-4.06B
0.00%
データなし
事業別
地域別
事業別USD
会社名
収益
比率
Pharmacy revenues
185.36B
0.00%
Network revenues
105.34B
0.00%
Home delivery and specialty revenues
72.48B
0.00%
Fees and other revenues
14.79B
0.00%
Other revenues
11.54B
0.00%
Intercompany eliminations
-4.06B
0.00%
株主
更新時刻: Fri, Feb 21
更新時刻: Fri, Feb 21
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.74%
BlackRock Institutional Trust Company, N.A.
4.97%
State Street Global Advisors (US)
4.67%
T. Rowe Price Associates, Inc.
4.36%
MFS Investment Management
4.23%
Other
72.03%
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.74%
BlackRock Institutional Trust Company, N.A.
4.97%
State Street Global Advisors (US)
4.67%
T. Rowe Price Associates, Inc.
4.36%
MFS Investment Management
4.23%
Other
72.03%
種類
株主統計
比率
Investment Advisor
43.07%
Investment Advisor/Hedge Fund
39.71%
Research Firm
2.47%
Pension Fund
2.25%
Bank and Trust
1.80%
Sovereign Wealth Fund
1.28%
Hedge Fund
1.27%
Corporation
1.19%
Individual Investor
0.39%
Other
6.57%
機関投資家保有株
更新時刻: Sun, Jan 19
更新時刻: Sun, Jan 19
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q1
2942
254.24M
95.14%
-4.47M
2024Q4
2993
255.45M
93.32%
-4.13M
2024Q3
2931
253.73M
90.72%
-10.03M
2024Q2
2910
254.99M
91.23%
-15.89M
2024Q1
2865
261.02M
89.38%
-14.30M
2023Q4
2815
267.28M
91.36%
-8.83M
2023Q3
2725
267.63M
91.08%
-13.20M
2023Q2
2737
270.13M
91.28%
-8.82M
2023Q1
2710
268.83M
90.70%
-14.56M
2022Q4
2688
273.82M
91.52%
-15.33M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
25.98M
9.58%
+22.81K
+0.09%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
13.39M
4.94%
+8.80K
+0.07%
Dec 31, 2024
State Street Global Advisors (US)
12.72M
4.69%
-105.73K
-0.82%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.56M
3.9%
-1.12M
-9.58%
Dec 31, 2024
MFS Investment Management
11.23M
4.14%
+489.58K
+4.56%
Dec 31, 2024
Fidelity Management & Research Company LLC
9.98M
3.68%
-1.68M
-14.38%
Dec 31, 2024
Dodge & Cox
8.77M
3.24%
-16.81K
-0.19%
Dec 31, 2024
Sanders Capital, LLC
8.05M
2.97%
+154.42K
+1.95%
Dec 31, 2024
Geode Capital Management, L.L.C.
5.96M
2.2%
+101.74K
+1.74%
Dec 31, 2024
GQG Partners, LLC
4.02M
1.48%
+737.10K
+22.44%
Dec 31, 2024
詳細を見る
関連ETF
更新時刻: Fri, Jun 6
更新時刻: Fri, Jun 6
銘柄名
比率
iShares U.S. Healthcare Providers ETF
11.44%
VictoryShares Free Cash Flow ETF
3.59%
Monarch Dividend Plus Index ETF
3.25%
VictoryShares US Multi-Factor Minimum Vol ETF
3.12%
Fidelity Blue Chip Value ETF
3.03%
Davis Select US Equity ETF
2.92%
Brandes US Value ETF
2.83%
Fidelity Fundamental Large Cap Value ETF
2.42%
Invesco S&P 500 Enhanced Value ETF
2.41%
iShares Large Cap Value Active ETF
2.29%
詳細を見る
iShares U.S. Healthcare Providers ETF
比率11.44%
VictoryShares Free Cash Flow ETF
比率3.59%
Monarch Dividend Plus Index ETF
比率3.25%
VictoryShares US Multi-Factor Minimum Vol ETF
比率3.12%
Fidelity Blue Chip Value ETF
比率3.03%
Davis Select US Equity ETF
比率2.92%
Brandes US Value ETF
比率2.83%
Fidelity Fundamental Large Cap Value ETF
比率2.42%
Invesco S&P 500 Enhanced Value ETF
比率2.41%
iShares Large Cap Value Active ETF
比率2.29%
配当金
過去5年間の配当金総支払額は 5.74B 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Jan 30, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option
Mar 05, 2025
Mar 20, 2025
Mar 05, 2025
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Jul 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option
Sep 04, 2024
Sep 19, 2024
Sep 04, 2024
Apr 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option
Jun 04, 2024
Jun 20, 2024
Jun 04, 2024
Feb 02, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option
Mar 06, 2024
Mar 21, 2024
Mar 05, 2024
Oct 25, 2023
CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 26, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option
Sep 06, 2023
Sep 21, 2023
Sep 05, 2023
Apr 26, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option
Jun 07, 2023
Jun 22, 2023
Jun 06, 2023
Feb 03, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option
Mar 08, 2023
Mar 23, 2023
Mar 07, 2023
Oct 26, 2022
CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022
Dec 06, 2022
Dec 21, 2022
Dec 05, 2022
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
tradingkey.logo
tradingkey.logo
当社が提供する日中データはRefinitivより配信されており、同社の利用規約が適用されます。終値データ(過去・現在)についてもRefinitivより提供されています。全ての相場情報は現地取引所時間で表示されます。米国株式のリアルタイム最終取引価格はNasdaqを通じて報告された取引のみを反映しています。日中データは最低15分遅れ、または各取引所の要件に準じて遅延配信されます。
* 当コンテンツ(分析資料・取引戦略等)は第三者プロバイダーであるTrading Centralより提供されており、記載の見解は分析官の独立した評価及び判断に基づくものです。投資家個々の投資目的や財務状況は考慮されておりません。
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。
KeyAI